Small molecule therapeutic for AF
Bioresorbable IVC filter for the prevention of pulmonary embolism
Novel drug candidate for stroke-related cerebral edema
Novel preeclampsia treatment
Atrial shunt for treatment of heart failure
CaMKII inhibitors for HF and AF
GIPR antagonist for inducing weight loss in obese patients with T2 Diabetes.
Novel ablation system for treatment of AF (Acquired by Boston Scientific in 2017)
Medical device to treat patients with pulmonary artery hypertension
Leadless extravascular pacing system for bradycardia
Reversible aptamer targeting von Willebrand Factor (vWF) for acute ischemic stroke (AIS) thrombolysis
small molecule anti-diabetic treatment
Allogeneic stem cell therapy after MI (NASDAQ: CAPR)
Implantable cardioversion for the treatment of AF
transcatheter mitral valve (Acquired by Edwards in 2015)
Remote ischemic conditioning for MI
percutaneously implanted device to restore tricuspid valve function
MAb for treatment of post-MI and ischemia reperfusion injury
Novel defibrillation waveform to reduce pain associated with ICD therapies
Mitochondrial biogenesis platform technology
Fully implantable, miniaturized circulatory support device for HF
Non-surgical approach to gastric bypass
PYY agonist for management and treatment of obesity
Antisense antifibrotic therapeutics for heart failure
VEG-F based gene therapy for lymphedema (NASDAQ: HRPMF)
Cloud-based remote arrhythmia monitoring
NIRF device for intracoronary artery imaging
Gene-based diagnostic for stroke
Small molecule therapeutic for cardiac surgery-associated acute kidney injury
Bioresorbable stent for multiple indications (NASDAQ:LYRA)
Novel biomarker for the screening and diagnosis of gestational diabetes
microRNAs for cardiovascular and oncology indications
device for epicardial ablation of ventricular tachycardia
counterpulsation device for the treatment of HF
Peptide therapeutics for treatment of MI and ischemia reperfusion injury (Acquired by Mesoblast in 2013)
Small molecule for pulmonary artery hypertension
Small molecule for the treatment of central nervous system edema (Acquired by Biogen in 2017)
Gene therapy for rare, familial form of dilated cardiomyopathy
Miniature wirelessly-powered implantable left atrial pressure sensor
Gene therapy for the regeneration of cardiac tissue
External support for saphenous vein grafts in CABG
Peptide therapeutic for the treatment of resistant hypertension
Peptide therapeutic for stroke
